Volume 19 - Issue 6 - June 2006

Technology In Practice »

Can Topical Cryotherapy Provide A Viable Alternative For Pain Relief?

By Anthony Leone, Special Projects Editor | 5378 reads | 0 comments

People who cannot take traditional pain medication for heel pain, sore arches or other podiatric problems may find comfort with Biofreeze (Performance Health, Inc.). The topical modality is designed to help relieve pain from sprains and sore muscles, among other aliments, according to the company.
Biofreeze is a topical cryotherapy analgesic that generates a cooling remedy that numbs painful areas and helps reduce inflammation, according to the manufacturer. The modality incorporates Ilex, a natural extract of holly, which is formulated in a base for topical application, according to Debra A



New Products »

Healing Wounds From The Onset

4753 reads | 0 comments

The latest in the universe of wound care products aims to treat a variety of ulcers and wounds.

Optase is indicated for healing dehiscent wounds as well as pressure, venous and arterial ulcers, according to the product’s manufacturer Onset Therapeutics. The company says the gel product is a capillary bed stimulant that both promotes healing and protects the wound bed area by acting as an occlusive barrier.
Optase is composed of balsam of Peru, castor oil and trypsin–BCT. The company says Optase decreases wound bed disruption during application and patients do not need a



Forum »

Did You Hear The One About The Bigoted Patient?

By John H. McCord, DPM | 2537 reads | 0 comments

The current paranoid hysteria of our country toward protecting our borders from illegal aliens, mainly those of color, has caused the revisit of an abscess on our national soul. Racial and ethnic slurs and jokes are back.
Following the civil rights battles of the 1960s, it became unacceptable to offend racial minorities. We did not have strict laws against racial jokes like other more developed countries such as the Netherlands but insulting jokes or comments seemed to cease.
I have a strict rule in my office that racial jokes and ethnic slurs are forbidden. Employees who forget this rule ge



Editor's Perspective »

Wound Classification Systems: Are They Significantly Utilized In Practice?

By Jeff Hall, Executive Editor | 5027 reads | 0 comments

The variety of classification systems for lower extremity wounds is stunning. There is the popular Wagner Ulcer Classification System, the University of Texas (UT) Diabetic Wound Classification System, the National Pressure Ulcer System, the PEDIS classification from the International Working Group for the Diabetic Foot and diabetic foot infection guidelines from the Infectious Diseases Society of America (IDSA) among other classification schemes.
In a guest column for our “Diabetes Watch” column (see page 20), Kathleen Satterfield, DPM, discusses some of these classification systems an



Orthotics Q&A »

Exploring Orthotic Indications For Various Conditions

Guest Clinical Editor: James Losito, DPM | 17193 reads | 0 comments

In this edition of “Orthotics Q&A,” the panelists discuss various issues ranging from indications for the Richie Brace, Arizona AFO and prefabricated orthoses to whether orthotic casting should reduce supinatus. Without further delay, here is what the panelists had to say.

Q: What are the indications for using a Richie brace versus using an Arizona brace?
A:
For Doug Richie Jr., DPM, each custom ankle foot orthotic (AFO) has a different clinical indication and choosing one to treat a pathology is the same as choosing a surgical procedure. He notes the rigid Arizona AFO has a mol



Feature »

A Guide To Orthobiologics In Podiatric Surgery

Moderator: Mark Dollard, DPM; Panelists: Luis Leal, DPM, Kieran Mahan, DPM, D. Scot Malay, DPM, MSCE, Glenn Weinraub, DPM, and Thomas Zgonis, DPM | 14295 reads | 0 comments

In our ongoing quest to find viable graft alternatives in bone fracture and primary osseous repair, the technology of orthobiologic bone substitutes continues to evolve. Traditionally, we have looked for replacement bone from sources within the patient’s own body. Indeed, autograft is widely considered the gold standard for grafting. While autograft bone is superior in its ability to provide osteogenic mesenchymal stem cells, it does have a couple of inherent problems, namely, a limited supply and morbidity associated with harvesting from donor sites.
Accordingly, we have brought together a



  • « Previous
  •  | Page 1 of 3 | 
  • Next »